GlassScriptPhysician profile
Hayley D Trimble
NPI 1295022960
$1,994.17
in general payments reported to CMS, 2019-2025
25 companies · $513 in 2025
The $513 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $41.11 · 2021: $95.05 · 2022: $701 · 2023: $205 · 2024: $296 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $430.15 | 2022 | |
| Daiichi Sankyo INC. | $193.01 | 2019-2024 | Injectafer |
| Exeltis, USA INC. | $189.18 | 2022-2025 | Slynd |
| Sage Therapeutics, LLC | $188.54 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $163.13 | 2019-2025 | |
| Abbvie INC. | $137.65 | 2019-2025 | Qulipta |
| Pfizer INC. | $123.39 | 2019-2023 | |
| Astellas Pharma US INC | $117.06 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $92.53 | 2024-2025 | Myfembree |
| Shield Therapeutics INC | $55.52 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $34.09 | 2019-2025 | Exparel |
| Hologic Sales and Service, LLC | $33.54 | 2022-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Merck Sharp & Dohme LLC | $26.60 | 2019-2024 | Gardasil 9, Gardasil |
| Dexcom, INC. | $25.13 | 2025 | Dexcom G6 Transmitter |
| Roche Diagnostics Corporation | $24.94 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $21.79 | 2023 | Aponvie |
| Axonics, INC. | $19.25 | 2024 | Axonics |
| Becton, Dickinson and Company | $18.71 | 2023 | Bd Surepath Collection Vial |
| Therapeuticsmd, INC. | $17.50 | 2022 | |
| Davol INC. | $14.81 | 2023 | Arista Ah Flexitip |
| Supernus Pharmaceuticals, INC. | $14.24 | 2025 | Qelbree |
| Gynesonics, INC. | $14.17 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Meditrina | $13.95 | 2024 | |
| Smith+Nephew, INC. | $12.78 | 2023 | Pico 7 |
| Nestle Healthcare Nutrition INC. | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayley Trimble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.